Clinical activity of futibatinib in currently studied areas with(out) combinations based on mechanistic rationale
Clinical activity of futibatinib with(out) combinations in new disease areas with unmet medical need that are not currently part of the futibatinib development plan
Quality of life, safety management (including compliance, dosing, etc.) and health care resource utilization with futibatinib in the real world
Pre-clinical activity of futibatinib to further support current clinical development plan and/or support rationale for use in new clinical settings
